Dr Natasha Jansz
Research Officer
Department of Microbiology and Immunology
25 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
Immunophenotype and proviral landscape of HTLV-1c infection and pulmonary disease
DOI: 10.1016/j.ebiom.2026.1064032026
Journal article
X-chromosome inactivation draws L1 mutagenesis to the human X chromosome.
DOI: 10.1126/science.adz80812026
Journal article
TBP regulates transposable element expression in early mouse embryos
DOI: 10.1038/s44318-026-00736-w2025
Research grants (other domestic)
Using Epigenetic Therapies to Target HTLV-1
2025
Journal article
The silence within: a conserved intragenic silencing element governs HTLV-1 expression via host RUNX1 complex binding
DOI: 10.1038/s44298-025-00136-72025
Research grants (ARC, NHMRC, MRFF)
Control of Endemic HTLV-1 to Prevent Silent Global Spread
2024
Research grants (ARC, NHMRC, MRFF)
Transposable Elements as Regulators of Genome Architecture During in Vivo Epigenetic Reprogramming
RECENT SCHOLARLY WORKS
2025
Journal article
Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo
DOI: 10.1016/j.cell.2025.06.0232025
Journal article
OGT prevents DNA demethylation and suppresses the expression of transposable elements in heterochromatin by restraining TET activity genome-wide
DOI: 10.1038/s41594-025-01505-92024
Journal article
High level of genomic divergence in orf-I p12 and hbz genes of HTLV-1 subtype-C in Central Australia
DOI: 10.1186/s12977-024-00647-w2024
Journal article
LINE-1 retrotransposons contribute to mouse PV interneuron development
DOI: 10.1038/s41593-024-01650-22024
Journal article
Viral genome sequencing methods: benefits and pitfalls of current approaches
DOI: 10.1042/BST202313222023
Journal article
SMCHD1 has separable roles in chromatin architecture and gene silencing that could be targeted in disease
DOI: 10.1038/s41467-023-40992-6